MX2008009493A - Peptido novedoso y uso del mismo. - Google Patents

Peptido novedoso y uso del mismo.

Info

Publication number
MX2008009493A
MX2008009493A MX2008009493A MX2008009493A MX2008009493A MX 2008009493 A MX2008009493 A MX 2008009493A MX 2008009493 A MX2008009493 A MX 2008009493A MX 2008009493 A MX2008009493 A MX 2008009493A MX 2008009493 A MX2008009493 A MX 2008009493A
Authority
MX
Mexico
Prior art keywords
amino acid
acid sequence
peptide
novel peptide
seq
Prior art date
Application number
MX2008009493A
Other languages
English (en)
Inventor
Sung-Hoon Kim
Jung-Min Han
Original Assignee
Imagene Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imagene Co Ltd filed Critical Imagene Co Ltd
Publication of MX2008009493A publication Critical patent/MX2008009493A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se relaciona con un péptido novedoso y uso del mismo, más en particular a un péptido aislado que comprende 21-41 aminoácidos contiguos seleccionados de la secuencia de aminoácido de SEQ ID NO:1 o la secuencia de aminoácido que tiene al menos una homología de secuencia de 90% con la secuencia de aminoácido de SE! ID NO: 1 y métodos para promover la proliferación de fibroblastos y curación de heridas, que comprende administrar a un sujeto que lo necesite una cantidad efectiva de) péptido.
MX2008009493A 2006-01-23 2006-01-23 Peptido novedoso y uso del mismo. MX2008009493A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2006/000252 WO2007083853A1 (en) 2006-01-23 2006-01-23 Novel peptide and use thereof

Publications (1)

Publication Number Publication Date
MX2008009493A true MX2008009493A (es) 2008-10-03

Family

ID=38287791

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008009493A MX2008009493A (es) 2006-01-23 2006-01-23 Peptido novedoso y uso del mismo.

Country Status (9)

Country Link
US (1) US20090305973A1 (es)
EP (1) EP1976864B1 (es)
JP (1) JP5002603B2 (es)
KR (1) KR101020658B1 (es)
CN (1) CN101370821B (es)
AU (1) AU2006335748A1 (es)
CA (1) CA2640064A1 (es)
MX (1) MX2008009493A (es)
WO (1) WO2007083853A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006083087A1 (en) * 2005-02-01 2006-08-10 Imagene Co., Ltd. Method for stimulation collagen synthesis and/or kgf expression
WO2008086358A1 (en) 2007-01-08 2008-07-17 University Of Southern California Usc Stevens Skin wound healing compositions and methods of use thereof
JP2010526527A (ja) * 2007-02-01 2010-08-05 イマジーン・カンパニー・リミテッド 抗腫瘍活性を有する新規なポリペプチド
CN101824083B (zh) * 2009-03-06 2014-01-15 信谊药厂 C端缺失型p43蛋白及其在肿瘤治疗药物中的应用
CA2755784C (en) 2009-03-16 2020-03-24 Pangu Biopharma Limited Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
US8207118B2 (en) 2009-07-17 2012-06-26 University Of Southern California Skin wound healing compositions and methods of use thereof
CN106474462A (zh) 2009-12-11 2017-03-08 Atyr 医药公司 用于调节炎症的氨酰tRNA合成酶
KR20180059953A (ko) 2010-07-12 2018-06-05 에이티와이알 파마, 인코포레이티드 히스티딜­trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
CN103458914B (zh) * 2010-11-03 2015-11-25 南加利福尼亚大学 皮肤伤口愈合组合物及其使用方法
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
US9822353B2 (en) 2011-12-06 2017-11-21 Atyr Pharma, Inc. PEGylated aspartyl-tRNA synthetase polypeptides
US9688978B2 (en) 2011-12-29 2017-06-27 Atyr Pharma, Inc. Aspartyl-tRNA synthetase-Fc conjugates
EP2814514B1 (en) 2012-02-16 2017-09-13 Atyr Pharma, Inc. Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
DK2970921T3 (en) 2013-03-15 2019-01-14 Atyr Pharma Inc Histidyl-tRNA synthetase-Fc conjugates
KR101969904B1 (ko) * 2016-03-23 2019-04-18 주식회사 카인사이언스 피부 재생 또는 상처 치료용 펩타이드 및 이의 용도
US10995117B2 (en) 2016-03-23 2021-05-04 Kine Sciences Co., Ltd. Peptide for skin regeneration or wound treatment and use thereof
KR101996490B1 (ko) * 2016-05-31 2019-07-03 인하대학교 산학협력단 간질환 예방 또는 치료용 펩타이드 및 이를 유효성분으로 포함하는 조성물
KR102336341B1 (ko) * 2016-07-28 2021-12-08 주식회사 네오믹스 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 피부 보호용 조성물
KR102017796B1 (ko) * 2016-07-28 2019-09-03 주식회사 큐어바이오 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물
WO2018195338A1 (en) 2017-04-20 2018-10-25 Atyr Pharma, Inc. Compositions and methods for treating lung inflammation
KR102346050B1 (ko) * 2019-01-25 2022-01-03 주식회사 네오믹스 미백 활성을 갖는 신규 폴리펩타이드 및 이의 용도
KR102024055B1 (ko) * 2019-08-14 2019-09-24 주식회사 큐어바이오 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5155214A (en) 1984-03-05 1992-10-13 The Salk Institute For Biological Studies Basic fibroblast growth factor
US5556645A (en) * 1990-01-12 1996-09-17 Bockman; Richard Methods of enhancing wound healing and tissue repair
US5886141A (en) * 1990-10-26 1999-03-23 Takeda Chemical Industries, Ltd. Smooth muscle mitogen peptides and DNA coding therefor
US5981606A (en) * 1991-03-01 1999-11-09 Warner-Lambert Company Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same
US5149691A (en) 1991-03-12 1992-09-22 Creative Biomolecules, Inc. Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II
US6800286B1 (en) 1998-08-19 2004-10-05 The Regents Of The University Of Colorado Chimeric fibroblast growth factor proteins, nucleic acid molecules, and uses thereof
WO2000029620A1 (en) * 1998-11-13 2000-05-25 Children's Hospital Of Los Angeles Methods of facilitating vascular growth
US6616648B2 (en) * 2000-03-31 2003-09-09 Sca Hygiene Products Ab Absorbent article having v-shaped elastic attached to backsheet
KR100405919B1 (ko) * 2001-06-05 2003-11-14 주식회사 이매진 ｐ43의 Ｎ-말단 펩타이드를 유효성분으로 하는 면역증강용 약학조성물
KR100515016B1 (ko) * 2002-07-22 2005-09-15 재단법인서울대학교산학협력재단 ｐ43을 유효성분으로 하는 창상 치료용 약학적 조성물
WO2006083087A1 (en) * 2005-02-01 2006-08-10 Imagene Co., Ltd. Method for stimulation collagen synthesis and/or kgf expression
JP2010526527A (ja) * 2007-02-01 2010-08-05 イマジーン・カンパニー・リミテッド 抗腫瘍活性を有する新規なポリペプチド

Also Published As

Publication number Publication date
US20090305973A1 (en) 2009-12-10
WO2007083853A1 (en) 2007-07-26
CN101370821A (zh) 2009-02-18
JP5002603B2 (ja) 2012-08-15
EP1976864A1 (en) 2008-10-08
JP2009523844A (ja) 2009-06-25
CA2640064A1 (en) 2007-07-26
AU2006335748A1 (en) 2007-07-26
KR101020658B1 (ko) 2011-03-09
KR20080103511A (ko) 2008-11-27
CN101370821B (zh) 2012-07-18
EP1976864B1 (en) 2012-09-26
EP1976864A4 (en) 2010-09-01

Similar Documents

Publication Publication Date Title
MX2008009493A (es) Peptido novedoso y uso del mismo.
NZ600690A (en) Fkbp-l and uses thereof
IN2014CN02050A (es)
NZ601868A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
NZ599161A (en) Method for activation of helper t cell and composition for use in the method
MX348464B (es) Agente inductor de inmunidad.
NZ595063A (en) Polypeptides from neisseria meningitidis
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
EA201170878A1 (ru) Полипептиды с ксиланазной активностью
MX2009008270A (es) Polipeptido novedoso que tiene actividad anti-tumoral.
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
NZ597306A (en) Mesenchymal stem cell differentiation
NZ607892A (en) Tfpi inhibitors and methods of use
WO2011038900A3 (en) Peptide analogues of glucagon for diabetes therapy
EP2039367A4 (en) PROPHYLACTIC / THERAPEUTIC AGENT FOR NEURODEGENERATIVE DISEASES
NZ703514A (en) Fviii peptides for immune tolerance induction and immunodiagnostics
NZ614557A (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
WO2010057242A3 (de) Vakzin
HK1121383A1 (en) Wound healing agent and composition
WO2008047370A3 (en) Compositions and methods for inducing angiogenesis
EP3026057A3 (en) Compositions for prevention and treatment of neurodegenerative diseases
EP1765851A4 (en) OPTICAL CHEMO AND BIOSENSORS BASED ON A PLANAR RESONATOR
NZ591827A (en) Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject
HK1131162A1 (en) Cytokine derivatives

Legal Events

Date Code Title Description
FG Grant or registration